BiotechTube
Home/Pipeline/Platform Expansion - Other Specialty Molecules

Platform Expansion - Other Specialty Molecules

Various

DevelopmentActive

Key Facts

Indication
Various
Phase
Development
Status
Active
Company
River Stone Biotech

About River Stone Biotech

River Stone Biotech is a private, Copenhagen-based company leveraging a hybrid synthetic biology and chemistry platform to reinvent the supply chain for high-value, complex APIs. Its initial commercial focus is on producing opioid use disorder treatments and prostaglandins, aiming to reduce cost, complexity, and environmental impact. The company has secured key patents, published significant research, and announced a global commercial launch as of late 2023, positioning it as a disruptive specialty API manufacturer.

View full company profile

Therapeutic Areas

Opioid Use DisorderAlcohol Use DisorderReproductive HealthGlaucomaCardiovascular

Other Various Drugs

DrugCompanyPhase
New Generic ApprovalsChina SXT PharmaceuticalsApplication Submitted / BE Stage
New Dosage Form DevelopmentUniverse PharmaceuticalsDevelopment
New TCM Formula RegistrationUniverse PharmaceuticalsDevelopment
CBD/THC Oil FormulationAvecho BiotechnologyPreclinical
Bag APIsChemWerthApproved
Oral APIsChemWerthApproved
Companion Diagnostics DevelopmentKiffik BiomedicalPre-clinical
Portfolio of Complex Generics & 505(b)(2) ProductsAlvogenApproved/Commercial
Portfolio of 40+ productsPraxgen PharmaceuticalsDevelopment
Drug Repositioning ServiceBiovistaService
Custom Control DevelopmentAnchor MolecularDevelopment/Commercial
Portfolio from Steriscience PartnershipArmas PharmaceuticalsANDA Development/Filing